Skip to main content

Advertisement

SpringerLink
Log in

Closure of patent foramen ovale in the prevention of migraine: not enough evidence in favor

  • Viewpoint
  • Published:

From Nature Clinical Practice Neurology

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Diener HC et al. (2007) Patent foramen ovale and migraine. Curr Pain Headache Rep 11: 236–240

    Article  Google Scholar 

  2. Wilmshurst P and Nightingale S (2006) The role of cardiac and pulmonary pathology in migraine: a hypothesis. Headache 46: 429–434

    Article  Google Scholar 

  3. Mortelmans K et al. (2005) The influence of percutaneous atrial septal defect closure on the occurrence of migraine. Eur Heart J 26: 1533–1537

    Article  Google Scholar 

  4. Lapergue B et al. (2006) Frequency of migraine attacks following stroke starts to decrease before PFO closure. Neurology 67: 1099–1100

    Article  CAS  Google Scholar 

  5. Dowson A et al. (2008) Migraine Intervention With STARFlex Technology (MIST) trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation 117: 1397–1404

    Article  Google Scholar 

  6. Mulder EJ et al. (2003) Genetic and environmental influences on migraine: a twin study across six countries. Twin Res 6: 422–431

    Article  Google Scholar 

  7. Wilmshurst PT et al. (2004) Inheritance of persistent foramen ovale and atrial septal defects and the relation to familial migraine with aura. Heart 90: 1315–1320

    Article  CAS  Google Scholar 

  8. Sackett DL et al. (1996) Evidence based medicine: what it is and what it isn't. BMJ 312: 71–72

    Article  CAS  Google Scholar 

  9. Maisel WH and Laskey WK (2005) Patent foramen ovale closure devices: moving beyond equipoise. JAMA 294: 366–369

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. M Schürks is Instructor of Medicine in the Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.,

    Markus Schürks

  2. H-C Diener is Chairman of the Department of Neurology and the Headache Center and Professor of Neurology, University of Duisburg-Essen, Essen, Germany.,

    Hans-Christoph Diener

Authors
  1. Markus Schürks
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hans-Christoph Diener
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hans-Christoph Diener.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schürks, M., Diener, HC. Closure of patent foramen ovale in the prevention of migraine: not enough evidence in favor. Nat Rev Neurol 5, 22–23 (2009). https://doi.org/10.1038/ncpneuro0971

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneuro0971

  • Springer Nature Limited

Search

Navigation